{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"developmental-and-epileptic-encephalopathy-34","columns":[{"gene":"","key":"population-1bfb951bd378732f06f7","label":"Epileptic encephalopathy, early infantile, 34","mondoId":"MONDO:0014718","onsetQualifier":null,"originColumnKey":"MONDO:0014718/OMIM:616645","originalViews":[{"key":"MONDO:0014718/OMIM:616645","label":"Epileptic encephalopathy, early infantile, 34","scopeLabel":"OMIM:616645","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0a0393fc2a2679b50d4bc864ab447105cc3c599139079d71f1d9deeb6f113eac","379d13cca6eb597bd65a5f8b8a9aa9c10f408d0a204c70eaebb0c40a73db8bca","4c908cdc0ef228ab18b9c48b3c27588cbc927a17ef8c7eba737297eaae9fabe1","4dcc2427126ec081865501bf7ff3e85257468133a4d3c5bad1115c806c2173c6","5e8432ce8dd545462eaeab8a19efeafed21c93ed48e31f033d59ea2cae081343","6d96e20f3a7694255eb3f1619510ed9f9efe0428142a02fce6c9ff217635f59f","7b31d7b407cce878da613b78f4c68e1a6c44ddd385d3ec7aa6b9482792589577","8c538ea337d37cfdd1c425352d2f61e039489de899b16af6400249aaabc4a1b0","b662d6a77fc7c661b0fc7d4c07e3b93af6e459467ea59726d9a378cb8cc885c8","c0f0755ad22610c99c31dd3da6b169c0a84648188f4f76cee5f3169e210c8965","c422332fece1316d57745f87c16028f67f70a191d424456d1fad7400432531e7","d9780430103eb63c0d0edc4319041552ed5c27dbf50480d2eeafc9798d4833fa","e11c613e992ba14b19f30ffce8e6fa2ef9b177a483d7419bf6dab8110dd2023d","f7e5d9f03544ed0df54091e35bae5ddc33af5a9400cdaa5ad1e725e8155f774c"],"recordQualifiers":{},"scopeLabel":"OMIM:616645","sourceIds":["OMIM:616645"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-1bfb951bd378732f06f7"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0007256","HP:0007334","HP:0002059","HP:0002188","HP:0002376","HP:0003781","HP:0006813"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":14,"sourceGroups":{"omim":2,"published":12}},"features":[{"hpoId":"HP:0007256","label":"Abnormal pyramidal sign","primary":true},{"hpoId":"HP:0007334","label":"Bilateral tonic-clonic seizure with focal onset","primary":true},{"hpoId":"HP:0002059","label":"Cerebral atrophy","primary":true},{"hpoId":"HP:0002188","label":"Delayed CNS myelination","primary":true},{"hpoId":"HP:0002376","label":"Developmental regression","primary":true},{"hpoId":"HP:0003781","label":"Excessive salivation","primary":true},{"hpoId":"HP:0006813","label":"Focal hemiclonic seizure","primary":true},{"hpoId":"HP:0007359","label":"Focal-onset seizure","primary":false},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":false},{"hpoId":"HP:0002540","label":"Inability to walk","primary":false},{"hpoId":"HP:0001249","label":"Intellectual disability","primary":false},{"hpoId":"HP:0005484","label":"Secondary microcephaly","primary":false},{"hpoId":"HP:0001250","label":"Seizure","primary":false},{"hpoId":"HP:0002133","label":"Status epilepticus","primary":false}],"ledeHtml":"Developmental and epileptic encephalopathy 34 (DEE34) is a rare neurological disorder. It is characterized by the onset of seizures in the first year of life. Seizures are observed after normal early development. The seizures caused by this condition are known as refractory migrating focal seizures. This type of seizure starts in one area of the brain and moves to another. The seizures are resistant to treatment with antiepileptic drugs (refractory). Children with DEE34 experience developmental regression and severe global impairment. This condition is caused by mutations in the SLC12A5 gene. It is inherited in an autosomal recessive pattern. This means that two copies of the mutated gene are required to cause the disease.","mondoId":"MONDO:0014718","node":{"canonicalSlug":"developmental-and-epileptic-encephalopathy-34","comparisons":[{"documentSha256":"38b72d795fa113dc0b129240dfe4cd2565969cec63b9441df04a5b9f4b02fe0e","key":"legacy-epilepsy-of-infancy-with-migrating-focal-seizures","kind":"legacy","label":"malignant migrating partial seizures of infancy","memberIds":["MONDO:0013389","MONDO:0014133","MONDO:0014718","MONDO:0017385"],"mondoId":"MONDO:0017385","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/epilepsy-of-infancy-with-migrating-focal-seizures.38b72d795fa113dc0b129240dfe4cd2565969cec63b9441df04a5b9f4b02fe0e.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Developmental and epileptic encephalopathy, 34","originalSourceId":"OMIM:616645","paragraphs":["Developmental and epileptic encephalopathy 34 (DEE34) is a rare neurological disorder. It is characterized by the onset of seizures in the first year of life. Seizures are observed after normal early development. The seizures caused by this condition are known as refractory migrating focal seizures. This type of seizure starts in one area of the brain and moves to another. The seizures are resistant to treatment with antiepileptic drugs (refractory). Children with DEE34 experience developmental regression and severe global impairment. This condition is caused by mutations in the SLC12A5 gene. It is inherited in an autosomal recessive pattern. This means that two copies of the mutated gene are required to cause the disease."],"rawAttribution":"MONDO:0014718","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:41:58Z","upstream":"PlainLanguagePilotV2-Jan24","url":"https://rarediseases.info.nih.gov/diseases/16147"},"ownColumnKeys":["population-1bfb951bd378732f06f7"],"publication":"published","relationships":[{"kind":"parent","label":"malignant migrating partial seizures of infancy","mondoId":"MONDO:0017385","slug":"epilepsy-of-infancy-with-migrating-focal-seizures"},{"kind":"parent","label":"neonatal-onset developmental and epileptic encephalopathy","mondoId":"MONDO:0100455","slug":"neonatal-onset-developmental-and-epileptic-encephalopathy"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"published","editorialReview":{"reviewedAt":"2026-10-26","decision":"corrected","reason":"Correct the gene symbol to SLC12A5.","sources":["https://www.ncbi.nlm.nih.gov/gene/57468/"],"originalNarrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Developmental and epileptic encephalopathy, 34","originalSourceId":"OMIM:616645","paragraphs":["Developmental and epileptic encephalopathy 34 (DEE34) is a rare neurological disorder. It is characterized by the onset of seizures in the first year of life. Seizures are observed after normal early development. The seizures caused by this condition are known as refractory migrating focal seizures. This type of seizure starts in one area of the brain and moves to another. The seizures are resistant to treatment with antiepileptic drugs (refractory). Children with DEE34 experience developmental regression and severe global impairment. This condition is caused by mutations in the SLA12A5 gene. It is inherited in an autosomal recessive pattern. This means that two copies of the mutated gene are required to cause the disease."],"rawAttribution":"MONDO:0014718","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:41:58Z","upstream":"PlainLanguagePilotV2-Jan24","url":"https://rarediseases.info.nih.gov/diseases/16147"},"claimHolds":[]}},"records":[{"frequencyKind":"reported","key":"0a0393fc2a2679b50d4bc864ab447105cc3c599139079d71f1d9deeb6f113eac","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616645","disease_name":"Epileptic encephalopathy, early infantile, 34","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0005484","is_excluded":false,"label":"Secondary microcephaly","onset_id":null,"reference":"PMID:26333769","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"379d13cca6eb597bd65a5f8b8a9aa9c10f408d0a204c70eaebb0c40a73db8bca","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616645","disease_name":"Epileptic encephalopathy, early infantile, 34","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0007256","is_excluded":false,"label":"Abnormal pyramidal sign","onset_id":null,"reference":"PMID:26333769","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"4c908cdc0ef228ab18b9c48b3c27588cbc927a17ef8c7eba737297eaae9fabe1","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616645","disease_name":"Epileptic encephalopathy, early infantile, 34","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0002059","is_excluded":false,"label":"Cerebral atrophy","onset_id":null,"reference":"PMID:26333769","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"4dcc2427126ec081865501bf7ff3e85257468133a4d3c5bad1115c806c2173c6","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616645","disease_name":"Epileptic encephalopathy, early infantile, 34","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"PMID:26333769","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"5e8432ce8dd545462eaeab8a19efeafed21c93ed48e31f033d59ea2cae081343","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616645","disease_name":"Epileptic encephalopathy, early infantile, 34","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0002133","is_excluded":false,"label":"Status epilepticus","onset_id":null,"reference":"PMID:26333769","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"6d96e20f3a7694255eb3f1619510ed9f9efe0428142a02fce6c9ff217635f59f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616645","disease_name":"Epileptic encephalopathy, early infantile, 34","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0007359","is_excluded":false,"label":"Focal-onset seizure","onset_id":null,"reference":"PMID:26333769","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"7b31d7b407cce878da613b78f4c68e1a6c44ddd385d3ec7aa6b9482792589577","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616645","disease_name":"Epileptic encephalopathy, early infantile, 34","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0006813","is_excluded":false,"label":"Focal hemiclonic seizure","onset_id":null,"reference":"PMID:26333769","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"8c538ea337d37cfdd1c425352d2f61e039489de899b16af6400249aaabc4a1b0","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616645","disease_name":"Epileptic encephalopathy, early infantile, 34","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0002188","is_excluded":false,"label":"Delayed CNS myelination","onset_id":null,"reference":"PMID:26333769","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"b662d6a77fc7c661b0fc7d4c07e3b93af6e459467ea59726d9a378cb8cc885c8","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616645","disease_name":"Epileptic encephalopathy, early infantile, 34","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002376","is_excluded":false,"label":"Developmental regression","onset_id":null,"reference":"OMIM:616645","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"c0f0755ad22610c99c31dd3da6b169c0a84648188f4f76cee5f3169e210c8965","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616645","disease_name":"Epileptic encephalopathy, early infantile, 34","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0002540","is_excluded":false,"label":"Inability to walk","onset_id":null,"reference":"PMID:26333769","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"c422332fece1316d57745f87c16028f67f70a191d424456d1fad7400432531e7","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"OMIM:616645","disease_name":"Epileptic encephalopathy, early infantile, 34","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0003781","is_excluded":false,"label":"Excessive salivation","onset_id":null,"reference":"PMID:26333769","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"d9780430103eb63c0d0edc4319041552ed5c27dbf50480d2eeafc9798d4833fa","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616645","disease_name":"Epileptic encephalopathy, early infantile, 34","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0007334","is_excluded":false,"label":"Bilateral tonic-clonic seizure with focal onset","onset_id":null,"reference":"PMID:26333769","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"e11c613e992ba14b19f30ffce8e6fa2ef9b177a483d7419bf6dab8110dd2023d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616645","disease_name":"Epileptic encephalopathy, early infantile, 34","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"PMID:26333769","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"f7e5d9f03544ed0df54091e35bae5ddc33af5a9400cdaa5ad1e725e8155f774c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616645","disease_name":"Epileptic encephalopathy, early infantile, 34","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"OMIM:616645","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/16147\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0014718\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>PlainLanguagePilotV2-Jan24</dd></dl></details><p class=\"section-source\">Source clarification. <a href=\"https://www.ncbi.nlm.nih.gov/gene/57468/\" rel=\"noreferrer\">1</a></p>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Developmental and epileptic encephalopathy 34 (DEE34) is a rare neurological disorder. It is characterized by the onset of seizures in the first year of life. Seizures are observed after normal early development. The seizures caused by this condition are known as refractory migrating focal seizures. This type of seizure starts in one area of the brain and moves to another. The seizures are resistant to treatment with antiepileptic drugs (refractory). Children with DEE34 experience developmental regression and severe global impairment. This condition is caused by mutations in the SLC12A5 gene. It is inherited in an autosomal recessive pattern. This means that two copies of the mutated gene are required to cause the disease.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/16147\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"developmental-and-epileptic-encephalopathy-34","sourceDocuments":[{"name":"GARD: Developmental and epileptic encephalopathy, 34","reviewed":null,"source_release":"2026-10-25T03:41:58Z","url":"https://rarediseases.info.nih.gov/diseases/16147"},{"name":"MONDO: developmental and epileptic encephalopathy, 34","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0014718"}],"sourceNote":"","synonyms":["DEE34","developmental and epileptic encephalopathy 34","early infantile epileptic encephalopathy caused by mutation in SLC12A5","EIEE34","epileptic encephalopathy, early infantile, 34","epileptic encephalopathy, early infantile, 34; EIEE34","epileptic encephalopathy, early infantile, type 34","SLC12A5 early infantile epileptic encephalopathy"],"takeawayHtml":"","title":"developmental and epileptic encephalopathy, 34"},"schemaVersion":1}
